CPT® Code 81362

The CPT® Code 81362 pertains to the analysis of the HBB gene, specifically focusing on known familial variants associated with hemoglobin disorders. The HBB gene encodes the beta-globin protein, which is a crucial component of hemoglobin, the protein responsible for oxygen transport in red blood cells (RBCs). Hemoglobin is composed of two beta-globin subunits, produced by the HBB gene, and two alpha-globin subunits, produced by the HBA gene. The HBB gene is located on the short arm of chromosome 11 and plays a significant role in various hemoglobinopathies, including sickle cell anemia and beta thalassemia. Mutations in the HBB gene can lead to significant health issues. For instance, in sickle cell anemia, a specific mutation results in the substitution of the amino acid glutamic acid with valine at position 6 of the beta-globin chain, leading to the formation of hemoglobin S (HbS). This abnormal hemoglobin causes red blood cells to assume a sickle shape, which can obstruct blood flow and lead to pain and organ damage. Similarly, beta thalassemia is characterized by mutations that either reduce or completely halt the production of beta-globin, resulting in anemia and related complications. The analysis performed under CPT® Code 81362 is essential for identifying specific mutations within the HBB gene that may be inherited within families. This testing is particularly valuable for individuals with a family history of hemoglobin disorders, as it can aid in preconception screening and help determine carrier status. The testing process typically involves obtaining a blood sample, which is then analyzed using advanced techniques such as polymerase chain reaction (PCR) and sequencing methods. This code specifically addresses the identification of known familial variants, distinguishing it from other codes that cover common variants or full gene sequencing.